NCI

Grant enhances study of new chemotherapy targets

Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Diabetes drug may prevent cancer

The research suggests that metformin should be further studied clinically for the prevention of liver cancer.

New histoplasmosis risk map

The new mapping approach, called suitability score mapping, should improve public health assessments and interventions for geographic-specific infections.

array of test tubes with pipette dropping fluid into one

Unleashing TIGER on small RNAs

Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.

Energetic gene switch

New findings link flux through glycolysis, which produces cellular energy, with transcription and gene expression via histone modification.

A new target for lung cancer

Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease.

1 9 10 11 12 13 28